Introduction {#Sec1}
============

Until recently, primary headaches such as migraine and cluster headache (CH) were described as vasomotor headaches \[[@CR1]\]. Initial positron emission tomography (PET) images shed light on the origins of these syndromes, documenting activation in the mesencephalic and pons regions for migraine, and in the grey hypothalamus for CH and others of trigeminal autonomic cephalalgias (TACs) \[[@CR2]--[@CR4]\].

TACs include CH, paroxysmal headache and Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT syndrome). It is interesting to note that the common clinical aspects of this primary headaches, where posterior hypothalamic activation has been reported, concern the important cranial autonomic symptoms. The concept of TACs indicates a possible common physiopathological base for these syndromes, not shared with other primary headaches, such as migraine or tension-type headache.

PET and functional magnetic resonance imaging (f-MRI) may be regarded as of little or no importance within a clinical context, but they offer great potential for the exploration of headache physiopathology and the effects of pharmacological treatment \[[@CR4]\]. In recent years, f-MRI studies have been conducted in TACs, but to date, no studies dealing with CH are available. In the present study we have investigated the cerebral activation centre during a CH attack in four patients with episodic CH, using f-MRI.

Materials and methods {#Sec2}
=====================

We enroled four patients (45 ± 4 years) diagnosed with episodic CH in accordance with the International Headache Society (IHS) classification (code 3.1.1) \[[@CR5]\].

All patients were in the active phase of the illness, and had an average frequency of two episodes a day. In three patients, one of the two attacks had a very regular recurrence (2 p.m.), while in the other patient it happened at night (11 p.m.). The average headache duration, without recourse to treatment, was 110 ± 12 min. All patients showed autonomic symptoms and there was no family history of headaches.

The patients reported no cardiovascular (hypertension and/or ischaemic cardiopathy), cerebrovascular risk factors, or internal pathological symptoms. All patients reported pain on the left side. A prerequisite for patient enrolment, established on the basis of medical history, was a dramatic response to subcutaneous sumatriptan administration (6 mg). Informed consent was obtained and the study was approved by the local Ethics Committee.

Study design {#Sec3}
------------

The functional study of each individual patient took place in a single continuative session, without interruptions. A priori, the duration of the functional examination was established (the same amount of time for each patient) to be long enough to allow registration of the asymptomatic state, the onset of pain and the pain relief-state (provided by administration of drugs). The patients in the study presented attacks at around the same time each day, and this allowed us to place them in the scanner, 15 min before the onset. When pain occurred they should communicate the onset by pressing buttons on a nonmagnetic button-box.

After 5 min, in order to avoid movements of the patients due to the pain and to induce the state of pain-relief, sumatriptan was subcutaneously injected. The end of attack was communicated using the same push-button controls.

Data acquisition {#Sec4}
----------------

Data was acquired on a 1.5 T scanner (Maestro Symphony, Siemens). Functional datasets were obtained by means of a T2\* weighted gradient echo-EPI pulse sequence (TR/TE/FA 3,000 ms/60 ms/30°, TR delay 20 ms, FOV 20 cm, matrix 64 × 64, voxel 3.125 × 3.125 × 5 mm^3^, gap 1.25 mm). We acquired 20 oblique axial slices, parallel to the anterior-posterior commissure plane, extending from the foramen magnum to the vertex. 400 functional images were acquired. Anatomical datasets were obtained using a T1 MP-RAGE 3D pulse sequence (TR/TI/TE/FA 2,160 ms/1,100 ms/3.93 ms/10°, voxel 1 × 1 × 1.4 mm^3^, gap 0.7 mm). 160 oblique sagittal slices were acquired.

Pre-processing of MRI data {#Sec5}
--------------------------

Data analysis was carried out using BrainVoyager QX 1.8 software. First, functional data was processed in order to increase the SNR ratio and reduce artefacts. We performed slice scan time correction and 3D motion correction by means of rigid body transformations (the estimated displacement in each direction was less than 3 voxels in each subject) and spatial smoothing with a Gaussian kernel of 4 mm FWHM (Full-Width-Half-Maximum). Anatomical data was re-sampled to obtain isometric voxels of 1 × 1 × 1 mm^3^ then normalised to the Talairach and Tournaux standard space \[[@CR6]\] to allow intersession statistical analysis. Functional and anatomical datasets were co-registered by translation, rotation and zoom operations on the *x*, *y* and *z* axis. Condition specific effects (pain vs. no pain) were estimated using a boxcar approach connected with the hemodynamic response function. Processed functional data obtained from the patients underwent single-subject and multi-subject General Linear Model (GML) analysis. A statistical map was generated as t-contrast with a threshold value of *P* \< 0.001. Activation was considered significant at a threshold of 0.05 corrected for multiple comparisons.

Results {#Sec6}
=======

During execution of functional MRI (three afternoon sessions and one night session) all the patients suffered from CH attacks, and the administration of sumatriptan brought pain relief after 4 ± 1 min (average values and standard deviation). In all attacks (single-subject GML study), comparing the pain state with the pain-free state, we detected significant cerebral activation (*P* \< 0.05, corrected for multiple comparisons) in the ipsilateral hypothalamic grey matter (Fig. [1](#Fig1){ref-type="fig"}). The coordinates and the *Z*-score of the activation zones are listed in Table [1](#Tab1){ref-type="table"}. Figure [2](#Fig2){ref-type="fig"} shows the temporal course of the BOLD signals in the hypothalamus ipsilaterally to the pain-side in patient 2. Additionally, with a less conservative threshold of *P* \< 0.001 uncorrected, trends of activation were observed in the pre-frontal cortex, anterior cingulate cortex, contralateral thalamus, ipsilateral basal ganglia and bilaterally in the insula and the cerebellar hemispheres. However, these areas were not subject to more detailed analysis because the study was not designed to investigate the activation of the pain matrix (stereotactic co-ordinates were not shown).Fig. 1Multi-subject GML analysis shows cerebral activation area in the posterior grey hypothalamus, ipsilateral to the pain side (*P* \< 0.001 uncorrected for descriptive purposes), superimposed on a T1-weighted anatomical reference MR image in axial (**a**) and coronal (**b**) planesTable 1BOLD-signal increases during spontaneous CH attack compared with the pain-free state (*P* \< 0.05, corrected for multiple comparisons)Talairach coordinates*Z*-score *P* \< 0.05 (corrected)*xyz*Patient 1−6−1014.89Patient 2−3−8−14.83Patient 3−5−644.91Patient 4−4−724.32Multi-subject study−5−8−16.93Fig. 2Temporal course of the BOLD signals in the hypothalamus ipsilaterally to the pain-side in patient 2. Asymptomatic state (**a**). Onset of the headache attack and state of pain (**b**). Administration of sumatriptan (**c**). Pain relief-state (**d**). On the horizontal line the number of the 400 GE-EPI acquisitions, is indicated

Discussion {#Sec7}
==========

This study documents the activation of cerebral areas normally attributed to the analysis of painful stimuli (pre-frontal cortex, basal ganglia, thalamus, cingulate cortex, insula and cerebellum) as reported in a comprehensive review \[[@CR7]\] and of the hypothalamic region ipsilaterally to the pain-side as documented in previous functional studies carried out using PET methods \[[@CR3]\] in CH. To date, f-MRI has only been used in the study of patients affected by other TACs. \[[@CR8]\] Previously, in short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing, f-MRI studies have shown both hypothalamic activation ipsilateral to the pain side \[[@CR9]\] and bilateral activation of the hypothalamus \[[@CR10]\]. In one case of atypical TAC \[[@CR11]\], activation of the hypothalamus, ipsilateral to the pain side, has been reported using f-MRI .

Overall, we have demonstrated the anatomical location of central nervous system activation with the first f-MRI study during a CH attack. The diencephalon-hypothalamic region seems to be an activation area specific to CH, and for this reason, the possible role of attack generator centres has been suggested. As suggested by clinical, biohumoral and electrophysiological data, the hypothalamus plays a role in determining biological rhythms \[[@CR12], [@CR13]\]. There is great need to investigate CH and other related idiopathic headache syndromes using f-MRI which offers a good balance of spatial and temporal resolution. The f-MRI presents major advantages in comparison with the PET: it does not use radioisotope administrative tracers (intravenously), but endogenous tracers (Deoxy-Haemoglobin). Furthermore f-MRI allows to effect anatomical and functional acquisitions in the same recording session.

This study method seems appropriate for investigation of pathogenetic aspects in the primary headaches, particularly for analysis of functional data immediately prior to attack onset.

None.
